Literature DB >> 19112740

A comment on blood transfusion practice resulting from the data on the prevalence of SEN virus DNA in donated blood samples.

Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19112740      PMCID： PMC2626907          DOI： 10.2450/2008.0023-08

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  7 in total

1.  Prevalence of a newly identified SEN virus in China.

Authors:  Shi-Jie Mu; Juan Du; Lin-Sheng Zhan; Hai-Ping Wang; Rui Chen; Quan-Li Wang; Wen-Ming Zhao
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

2.  The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan.

Authors:  M Shibata; R Y Wang; M Yoshiba; J W Shih; H J Alter; K Mitamura
Journal:  J Infect Dis       Date:  2001-07-06       Impact factor: 5.226

Review 3.  Emerging viral infections relevant to transfusion medicine.

Authors:  J P Allain
Journal:  Blood Rev       Date:  2000-12       Impact factor: 8.250

Review 4.  SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.

Authors:  Jun Akiba; Takeji Umemura; Harvey J Alter; Masamichi Kojiro; Edward Tabor
Journal:  Transfusion       Date:  2005-07       Impact factor: 3.157

5.  SEN virus infection in patients with chronic liver disease and hepatocellular carcinoma in Thailand.

Authors:  Pisit Tangkijvanich; Apiradee Theamboonlers; Maturapod Sriponthong; Duangporn Thong-Ngam; Pinit Kullavanijaya; Yong Poovorawan
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

6.  SEN virus infection does not affect the progression of non-A to -E liver disease.

Authors:  Morio Mikuni; Mitsuhiko Moriyama; Naohide Tanaka; Kenji Abe; Yasuyuki Arakawa
Journal:  J Med Virol       Date:  2002-08       Impact factor: 2.327

Review 7.  SEN virus infection.

Authors:  Abdurrahman Sagir; Oliver Kirschberg; Tobias Heintges; Andreas Erhardt; Dieter Häussinger
Journal:  Rev Med Virol       Date:  2004 May-Jun       Impact factor: 6.989
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.